GILENYA vs VUMERITY

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 21, 2026·How we rate

Possible drug interaction. GILENYA and VUMERITY are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	GILENYA	VUMERITY
Rating	70/100	New
Pharmacy pays	~$126.02 /30	—
Type	RX	RX
Active ingredient	FINGOLIMOD HYDROCHLORIDE	DIROXIMEL FUMARATE
Manufacturer	Novartis	Biogen
Dosage forms	Capsule	Capsule
Drug class	Sphingosine 1-Phosphate Receptor Modulator	—
Boxed warning	None	None
Half-life	about 6 to 9 days (average apparent terminal half-life)	—
Treats	Relapsing-Remitting Multiple Sclerosis	Demyelinating Diseases, Chronic Progressive Multiple Sclerosis, Relapsing-Remitting Multiple Sclerosis

gilenya vumerity

Rating

70/100

New

Pharmacy pays

~$126.02 /30

—

Type

Active ingredient

FINGOLIMOD HYDROCHLORIDE

DIROXIMEL FUMARATE

Manufacturer

Novartis

Biogen

Dosage forms

Capsule

Drug class

Sphingosine 1-Phosphate Receptor Modulator

—

Boxed warning

None

Half-life

about 6 to 9 days (average apparent terminal half-life)

—

Treats

Relapsing-Remitting Multiple Sclerosis

Demyelinating Diseases, Chronic Progressive Multiple Sclerosis, Relapsing-Remitting Multiple Sclerosis

Frequently asked questions

What is the difference between Gilenya and Vumerity?

Gilenya contains Fingolimod Hydrochloride, while Vumerity contains Diroximel Fumarate — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.